The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  66 (2024)
Volume  65 (2023)
Volume  64 (2022)
Volume  63 (2021)
Volume  62 (2020)
Volume  61 (2019)
Volume  60 (2018)
Volume  59 (2017)
Volume  58 (2016)
Volume  57 (2015)
Volume  56 (2014)
Volume  55 (2013)
Volume  54 (2012)
Volume  53 (2011)
Volume  52 (2010)
Related articles

VOLUME 63 , ISSUE 3 ( July-September, 2021 ) > List of Articles

REVIEW ARTICLE

Lung Cancer in India–Part I

D. Behera

Keywords : Lung cancer, India, Cancer Registry, Epidemiology, Histology, Dignosis, Management

Citation Information : Behera D. Lung Cancer in India–Part I. Indian J Chest Dis Allied Sci 2021; 63 (3):143-192.

DOI: 10.5005/ijcdas-63-3-143

License: CC BY-NC 4.0

Published Online: 18-11-2022

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Lung cancer in India has changed over the years. The subject was reviewed earlier in 2004. Since then, it has become an important and second common cancer in Indian males. Although smoking continued to be an important factor for the causation of lung cancer in this country, particularly bidi smoking, new facts come into light. Biomass fuel is another important factor in the causation of lung cancer in non-smoking females. There is also a regional disparity in the prevalence of lung cancer in India. Aizawl district had the highest rank in incidence rates in both males (38.8 per 100,000) and females (37.9 per 100,000). There was a significant increase in the incidence rates of lung cancer in Kamrup (urban), Chennai, Delhi and Bangalore PBCRs (Population Based Cancer Registries) in both males and females. Five PBCRs showed a significant increase in incidence rates among males whereas it was seen in 11 PBCRs among females. In Asia, among males, Yueyanglou (95.5 per 100,000) in China had the highest incidence rate of lung cancer, whereas Aizawl district (37.9 per 100,000), had the highest age adjusted ratio in females. Over the years, there is also marked improvement in the availability of diagnostic facilities all over the country. There is also a significant transition of the cell type of lung cancer. While earlier reports showed squamous cell type as the commonest one, now adenocarcinoma has surpassed that as reported from most centers in the country including the National Cancer Registry maintained by the Indian Council of Medical Research. Advent of molecular biology is a new development since we reviewed the topic nearly 16 years back. This aspect has been discussed in detail in the second part of the review. However, lung cancer continues to present in a very advanced stage of the disease where definite therapy, like surgery could not be offered to most of them. In fact around 3% to 4% of cases could only be offered surgery in our country. There is a significant improvement in the management of advanced stage lung cancer with the availability of newer chemotherapeutic drugs and targeted therapy and immunotherapy (will be discussed in 2nd part) with better median survival and many centers in the country are now treating this disease more aggressively. Although smoking continues to be a major problem in India, more and more anti-tobacco laws are being persued aggressively by the Government. Lung cancer screening is not yet practised in our country because of various technical, and other logistic issues. COVID-19 pandemic has created difficulties in managing such patients.

PDF Share
  1. History of Cancer. 19th Century. The Cancer Atlas. Available from URL: canceratlas.cancer.org history-cancer. Accessed on October 11, 2020.
  2. American Cancer Society. The History of Cancer. First Cancer Diagnosis. Available from URL: http://www.cancer.org cancer history-of-cancer. Accessed on October 11, 2020.
  3. Nath V, Grewal KS. Cancer in India. Indian J Med Res 1935;23:149–90.
  4. Behera D, Balamugesh T. Lung cancer in India. Indian J Chest Dis Allied Sci 2004;46:269–81.
  5. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1204–22.
  6. World Health Organization. Global Health Observatory. Geneva: World Health Organization; 2018. Available from URL: who.int/gho/database/en/. Accessed on October 10, 2020.
  7. World Health Organization. Global health estimates 2016: deaths by cause, age, sex, by country and by region, 2000-2016. Human Development Report 2016. Geneva: World Health Organization; 2018.
  8. American Cancer Society. Global Cancer Facts and Figures. 4th edition. Atlanta: American Cancer Society; 2018.
  9. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394–424.
  10. World Health Organization. Setting priorities, investing wisely and providing care for all. WHO Report on Cancer. Geneva: World Health Organization; 2020.
  11. https://canceratlas.cancer.org/wp-content/uploads/2019/09/CA3_LungCancer.pdf. Accessed on October 11, 2020.
  12. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49.
  13. National Cancer Institute, USA, 2020. Accessed on October 13, 2020.
  14. Varlotto JM, Voland R, McKie K, Flickinger JC, DeCamp MM, Maddox D, et al. Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease. Cancer Med 2018;7:1211–20.
  15. Lu T, Yang X, Huang Y, Zhao M, Li M, Ma K, et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Can Manage Res 2019:11 943–53.
  16. Centers for Disease Control and Prevention (CDC), the North American Association of Central Cancer Registries (NAACCR), the American Cancer Society (ACS), and the National Cancer Institute (NCI). Annual Report to the Nation on the Status of Cancer. National Cancer Institute, The Surveilance, Epidemiology, and End Result Program; 2020.
  17. Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 2018;103:356–87.
  18. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. the EUROCARE-5 Working Group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5: a population-based study. Lancet Oncol 2014;5:23–34.
  19. ECIS - European Cancer Information System. ECIS Contributing Initiatives and Studies. Accessed on October 13, 2020.
  20. Shin H, Clem M Carlos, Varghese C. Cancer control in the Asia Pacific region: current status and concerns. Japan J Clin Oncol 2012;42:867–81.
  21. Sekine I, Shintani Y, Shukuya T, Takayama K, Inoue A, Okamoto I, et al. A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients. Cancer Sci 2020;111:1685–91.
  22. Global Cancer Observatory, International Agency for Research on Cancer, WHO. Cancer burden in Japan. GLOBOCAN, 2018. Accessed on October 12, 2020.
  23. Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Communic 2020;40:205–21.
  24. Gao S, Li N, Wang S, Zhang F, Wei W, Li N, et al. Lung cancer in People's Republic of China. J Thorac Oncol 2020;15:1567–76.
  25. Behera D. Epidemiology of lung cancer: Global and Indian perspective. J Indian Acad Clin Med 2012;13:131–7.
  26. Noronha V, Dikshit R, Raut N, Joshi A, Pramesh CS, George K, et al. Epidemiology of lung cancer in India: focus on the differences between non-smokers and smokers: a single-centre experience. Indian J Cancer 2012;49:74–81.
  27. Parikh PM, Ranade AA, Govind B, Ghadyalpatil N, Singh R, Bharath R, et al. Lung cancer in India: current status and promising strategies. South Asian J Cancer 2016;5:93–95.
  28. Dubey AK, Gupta U, Jain S. Epidemiology of lung cancer and approaches for its prediction: a systematic review and analysis. Chinese J Cancer 2016;35:71–83.
  29. Noronha V, Pinninti R, Patil VM, Joshi A, Prabhash K. Lung cancer in the Indian subcontinent. South Asian J Cancer 2016;5:95–103.
  30. Behera D. Lung cancer in India: challenges and perspectives. J Thorac Oncol 2017;12:S114.
  31. Behera D, Maturu VN. Lung cancer. In: Droz JP, Carme B, Couppié P, Nacher M, Thiéblemont C, editors Tropical Hemato-Oncology. Springer: Cham. Available from URL: https://doi.org/10.1007/978-3-319-18257-5_37; 2015;363–72. Accessed on October 10, 2020.
  32. National Centre for Disease Informatics and Research. National Cancer Registry Programme. Report of National Cancer Registry Programme (2012-2016). Bengaluru, India: Indian Council of Medical Research; 2020.
  33. Dar MA, Sharma KK. Burden of cancer in India: Globocan 2018 estimates. Incidence, mortality, prevalence, and future projections of cancer in India. J Emerg Technol Invat Res 2019;6:505–14.
  34. India State-Level Disease Burden Initiative Cancer Collaborators. The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990–2016. Lancet Oncol 2018;19:1289–1306.
  35. Chandramohan K, Thomas B. Cancer trends and burden in India. Lancet Oncol 2018;19:E663.
  36. Viswanathan R, Gupta S, Iyer PVK. Incidence of primary lung cancer in India. Thorax 1962;17:73–76.
  37. Wig KL, Lazaro EJ, Gadekar NG, Guleria JS. Bronchogenic carcinoma: clinical features and diagnosis. Indian J Chest Dis 1961;3:209–18.
  38. Basu BK, Ghosh TN. A study of bronchogenic carcinoma. Indian J Chest Dis 1971;13:1–9.
  39. Sinha BC. Lung cancer: clinical features. Indian J Chest Dis 1961;3:209–18.
  40. Karai GS, Nath HK, Paul G, Saha D, Roy HK. Carcinoma of the lung: a record and analysis of 100 cases. Indian J Cancer 1967;4:105–13.
  41. Shankar PS. Bronchogenic carcinoma. Indian J Chest Dis 1967;9:161–4.
  42. Nagrath SP, Hazra DK, Lahiri B, Kishore B, Kumar R. Primary carcinoma of the lung: clinicopathological study of 35 cases. Indian J Chest Dis 1970;12:15–24.
  43. Reddy, DB, Prasanthamurthy D, Satyavathi S. Bronchogenic carcinoma: a clinico-pathological study. Indian J Chest Dis 1972;14:86–89.
  44. Guleria JS, Gopinath N, Talwar JR, Bhargava S, Pande JN, Gupta RG. Bronchial carcinoma: an analysis of 120 cases. J Assoc Physicians India 1971;19:251–5.
  45. Jha VK, Roy DC, Ravindran P. Bronchogenic carcinoma: a clinicopathological study. Indian J Chest Dis 1972;14:78–85.
  46. Nafae A, Misra SP, Dhar SN, Shah SNA. Bronchogenic carcinoma in Kashmir valley. Indian J Chest Dis 1973;15:285–95.
  47. Malik AK, Aikat BK. Primary pulmonary neoplasm: a histopathologic study. Indian J Cancer 1976;13:149–55.
  48. Narang RK, Dubey AL, Gupta MC, Raju S. Primary bronchial carcinoma: a clinical study. Indian J Chest Dis Allied Sci 1977;19:120–23.
  49. Jindal SK, Malik SK, Malik AK, Singh K, Gujral JS, Sodhi JS. Bronchogenic carcinoma: a review of 150 cases. Indian J Chest Dis Allied Sci 1979;21:59–64.
  50. Notani P, Sanghavi LD. A retrospective study of lung cancer in Bombay. Br J Cancer 1974;29:477–82.
  51. Garg UK, Srivastava VK, Rajwanshi VS, Maheshwari BB. Carcinoma of lung: a correlative cytological and histopathological study. Indian J Cancer 1973;10:204–11.
  52. Malhotra V, Malik R, Beohar PC, Gondal R, Khanna SK, Narayanan PS. Tumours of the lung: histomorphological study. Indian J Chest Dis Allied Sci 1986;28:28–40.
  53. Jindal SK, Behera D. Clinical spectrum of primary lung cancer: review of Chandigarh experience of 10 years. Lung India 1990;8:94–98.
  54. Arora VK, Seetharaman ML, Ramkumar S, Mamatha TV, Subbarao KSVK, Banerjee A, et al. Bronchogenic carcinoma: clinicopathological patten in south Indian population. Lung India 1990;7:133–8.
  55. Rao S, Rau PVP, Sahoo RC. Bronchogenic carcinoma in the young. Lung India 1992;10:101–2.
  56. Rajasekaran S, Manickam TG, Vasanthan PJ, et al. Pattern of primary lung cancer: a Madras study. Lung India 1993;9:7–11.
  57. Gupta RC, Purohit SD, Sharma MP, Bhardwaj S. Primary bronchogenic carcinoma: clinical profile of 279 cases from mid-west Rajasthan. Indian J Chest Dis Allied Sci 1998;40:109–16.
  58. Thippanna G, Venu K, Gopalkrishnaiah V, Reddy PNS, Sai Charan BG. A profile of lung cancer patients in Hyderabad. J Indian Med Assoc 1999;97:357–9.
  59. Arora VK, Sharma V, Reddy KS. Bronchogenic carcinoma in patients below age 40 years and the response to radiotherapy with or without CMF regime. Lung India 1998;16:155–8.
  60. Gupta D, Boffetta P, Gaborieau V, Jindal SK. Risk factors of lung cancer in Chandigarh, India. Indian J Med Res 2001;113:142–50.
  61. Kashyap S, Mohapatra PR, Negi RS. Pattern of primary lung cancer among bidi smokers in North-Western Himalayan region of India. Lung Cancer 2003;41 (Suppl. 2):S111.
  62. Prasad R, James P, Kesarwani V, Gupta R, Pant MC, Chaturvedi A, et al. Clinicopathological study of bronchogenic carcinoma. Respirology 2004;9:557–60.
  63. Khan NA, Afroz F, Lone M, Teli M, Muzaffar M, Jan N. Profile of lung cancer in Kashmir, India: a five-year study. Indian J Chest Dis All Sci 2006;48:187–90.
  64. Rawat J, Sindhwani G, Gaur D, Dua R, Saini S. Clinicopathological profile of lung cancer in Uttarakhand. Lung India 2009;26:74–76.
  65. Prasad R, Verma SK, Sanjay. Comparison between young and old patients with bronchogenic carcinoma. J Cancer Res Ther 2009;5:31–35.
  66. Koul PA, Kaul SK, Sheikh MM, Tasleem RA, Shah A. Lung cancer in the Kashmir valley. Lung India 2010;27:131–7.
  67. Sheikh S, Azra S, Aijaz A, Makhdoomi R, Rais A. Histological pattern of primary malignant lung tumours diagnosed in a tertiary care hospital: 10 year study. Asian Pac J Cancer Pre 2010;11:1341–6.
  68. Bhattacharyya SK, Mandal A, Deoghuria D, Agarwala A, Ghoshal AG, Dey SK. Clinico-pathological profile of lung cancer in a tertiary medical centre in India: analysis of 266 cases. J Dentistry Oral Hygiene 2011;3:30–33.
  69. Dey A, Biswas D, Saha SK, Kundu S, Kundu S, Sengupta A. Comparison study of clinicoradiological profile of primary lung cancer cases: an Eastern India experience. Indian J Cancer 2012;49:89–95.
  70. Noronha V, Dikshit R, Raut N, Joshi A, Pramesh CS, George K, et al. Epidemiology of lung cancer in India: focus on the differences between non-smokers and smokers: a single-centre experience. Indian J Cancer 2012;49:74–81.
  71. Bhaskarapillai B, Kumar SS, Balasubramanian S. Lung cancer in Malabar Cancer Center in Kerala: a descriptive analysis. Asian Pac J Cancer Prev 2012;13:4639–43.
  72. Mandal SK, Singh TT, Sharma TD, Amrithalingam V. Clinico-pathology of lung cancer in a regional cancer center in Northeastern India. Asian Pac J Cancer Prev 2013;14:7277–81.
  73. Malik PS, Sharma MC, Mohanti BK, Shukla NK, Deo S, Mohan A, et al. Clinico-pathological profile of lung cancer at AIIMS: a changing paradigm in India. Asian Pac J Cancer Prev 2013;14:489–94.
  74. Sundaram V, Sanyal N. Clinicopathological profile of bronchogenic carcinoma in a tertiary care hospital in eastern part of India. Clin Cancer Investig J 2014;3:220–4.
  75. Yogeesha KS, Vijayamahantesh NN, Raghavendra Bakki Sannegowda. Clinical presentation of lung cancer in adults: a retrospective study of 61 patients from a teritiary care centre in south India. Intern J Basic Appl Med Sci 2014;4:195–7.
  76. Dubey N, Julka A, Varudkar HG, Agrawat JC, Bhandari D, Mukati S, et al. A clinico-pathological profile of primary lung cancer patients presenting in a rural medical college of Central India. Panacea J Med Sci 2015;5:124–9.
  77. Pandhi N, Malhotra B, Kajal NC, Prabhudesai RR, Nagaraja CL, Mahajan N. Clinicopathological profile of patients with lung cancer visiting chest and TB hospital Amritsar. Sch J App Med Sci 2015;3:802–9.
  78. Baburao A, Narayanswamy H. Clinico-pathological profile and haematological abnormalities associated with lung cancer in Bangalore, India. Asian Pac J Can Prev 2016;16:8235–8.
  79. Dhandapani S, Srinivasan A, Rajagopalan R, Chellamuthu S, Rajkumar A, Palaniswamy P. Clinicopathological profile of lung cancer patients in a teaching hospital in South India. J Cardiothorac Med 2016;4:440–3.
  80. Pujari VV, Lokhande RM, Meshram SH, Waghmore RD. Clinical and pathological presentations of bronchogenic carcinoma in a tertiary care centre. J Evolution Med Dent Sci 2016;5:3068–71.
  81. Bhadke B, Rathod RK, Deshmukh DG, Luniya AB, Mahajan P, Surjushe AU. Clinical profile of lung cancer in rural medical college of Maharashtra (India): a prospective study of three years. Int J Med Res Rev 2016;4:1063–71.
  82. Kumar M, Sharma DK, Garg M, Jain P. Clinicopathological profile of lung cancer: changing trends in India. Int J Res Med 2016;5:57–62.
  83. Kshetrimayum S, Srivastava A, Kant S, Verma A, Ved P, Bajaj D, et al. A study of the sociodemographic, clinical, pathological and radiological profile of lung cancer in a tertiary care center. Int J Adv Med 2016;3:920–7.
  84. Neliyathodi S, Krishnan a, Gopinath D. Clinical radiological and immunohistochemical profile of non small cell lung carcinoma. South Am J Med 2016;4:1–12.
  85. Mohan A, Latifi AN, Guleria R. Increasing incidence of adenocarcinoma lung in India: following the global trend? Indian J Cancer 2016;53:92–5.
  86. Kaur H, Sehgal IS, Bal A, Gupta N, Behera D, Das A, et al. Evolving epidemiology of lung cancer in India: reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key. Indian J Cancer 2017;54:285–90.
  87. Nair CK, Mathew AP, George PS. Lung cancer: presentation and pattern of care in a cancer center in South India. Indian J Cancer 2017;54:164–8.
  88. Singh R, Rohtagi N. Clinicopathological and molecular epidemiological study of lung cancer patients seen at a tertiary care hospital in Northern India. South Asian J Cancer 2017;6:171–5.
  89. Sreekala C, Kumari KA, Jayaprakash B. Epidemiological pattern of lung cancer in a tertiary care centre: a prospective observational study. Int J Med Res Rev [Internet] 2017;5:839–44.
  90. Sharma T, Ghewade B, Jadhav U, Chaudhari S. Clinical profile of lung cancer at Acharya Vinoba Bhave Rural Hospital. J Datta Meghe Inst Med Sci Univ 2017;12:41–4.
  91. Vasu PP, Sujatha D, Leelamma JP. Clinical and cytomorphological evaluation of primary lung neoplasms in a tertiary care teaching centre of south India. J Evolution Med Dent Sci 2017;6:3240–5.
  92. Lakshmaiah KC, Kamath MP, Babu KG, Amirtham U, Loknatha D, Komaranchath AS. Metastatic nonsmall cell lung cancer in South India: a regional demographic study. Indian J Cancer 2017;54:267–70.
  93. George KC, TM A, Nambiar RK. Clinical, epidemiological and diagnostic profile of patients with carcinoma lung: a clinical study. J App Med Sci 2017;5:3714–8.
  94. Soman R, Govindaraj V, Saka V, Badhe B, Dubashi B. Clinico-pathological profile of primary lung cancer in a tertiary care center in South India. Indian J Immunol Respir Med 2018;3:165–9.
  95. Agrawal A, Tandon R, Singh L, Kumar P, Pant H, Prakash S. Clinical profile of lung cancer in a tertiary care teaching hospital in north India with special reference to acceptance and outcome of treatment. J Pulmon 2018;2:4–8.
  96. Sarfraz S, Gupta R, Bhardwaj S. Histopathological patterns of endobronchial lung biopsy specimen in lung cancer along with clinico-radiological correlation. Int J Contempor Med Res 2018;5:K1–K5.
  97. Dattatreya SP, Bansal R, Vamsy M, Vaniawala S, Nirni SS, Dayal M, et al. Clinicopathological profile of lung cancer at a tertiary care center. Indian J Cancer 2018;55:273.5.
  98. Thakkar D, Damor PK, Vithalani K. Clinicopathological profile of patients with bronchogenic carcinoma at a tertiary care center in Western India. Indian J Respir Care 2019;8:80.83.
  99. Pandey A, Raj S, Madhawi R, Devi S, Singh RK. Cancer trends in Eastern India: retrospective hospital-based cancer registry data analysis. South Asian J Cancer 2019;8:215.7.
  100. Ahmad DS, Waheed DA, Ahmad SS, Sunaullah K, Haneefa A, Subiya K, et al. A study of the sociodemographic, clinical and pathological profile of lung cancer: a study conducted at Government Medical College Srinagar, Kashmir, India. Int J Adv Res 2019;7:937.40.
  101. Raghavendra C, Gupta GRK, Reddy VVR. Clinicopathological profile of primary lung cancer in a tertiary care teaching hospital in the south-east coast of India. Indian J Immunol Respir Med 2019;4:205.9.
  102. Premananth P, Gnanasekaran R, Nagarajan N, Deiveegan. Lung cancer profile at tertiary care hospital, South Tamilnadu. Indian J Immunol Respir Med 2019;4:245.51.
  103. Gaur P, Bhattacharya S, Kant S, Kushwaha RA, Garg R, Pandey S, et al. Hospital-based study on demographic, hematological, and biochemical profile of lung cancer patients. J Cancer Res Ther 2020;16:839.42.
  104. Darling HS, Viswanath S, Singh R, Ranjan S, Pathi N, Rathore A, et al. A clinico-epidemiological, pathological, and molecular study of lung cancer in North-western India. J Can Res Ther 2020;16:771.9
  105. Mohan A, Garg A, Gupta A, Sahu S, Choudhari C, Vashistha V, et al. Clinical profile of lung cancer in North India: a 10-year analysis of 1862 patients from a tertiary care center. Lung India 2020;37:190.7.
  106. Parikh PM, Ranade AA, Govind B, Ghadyalpatil N, Singh R, Bharath R, et al. Lung cancer in India: current status and promising strategies. South Asian J Cancer 2016;5:93.5.
  107. Noronha V, Pinninti R, Patil VM, Joshi A, Prabhash K. Lung cancer in the Indian subcontinent. South Asian J Cancer 2016;5:95.103.
  108. Shankar A, Dubey A, Saini D, Singh M, Prasad CP, Roy S, et al. Environmental and occupational determinants of lung cancer. Transl Lung Cancer Res 2019;8 (Suppl. 1):S31.S49.
  109. D'Souza ND, Murthy NS, Aras RY. Projection of cancer incident cases for India.till 2026. Asian Pac J Cancer Prev 2013;14:4379.86.
  110. D'Souza ND, Murthy NS, Aras RY. Projection of burden of cancer mortality for India, 2011-2026. Asian Pac J Cancer Prev 2013;14:4387.92.
  111. Mohan S, Asthana S, Labani S, Popli G. Cancer trends in India: a review of population-based cancer registries (2005-2014). Indian J Public Health 2018;62:221.3.
  112. Krishnamurthy A, Vijayalakshmi R, Gadigi V, Ranganathan R, Sagar TG. The relevance of “nonsmokingassociated lung cancer” in India: a single-centre experience. Indian J Cancer 2012;49:82.8.
  113. Singh N, Behera D. Lung cancer epidemiology and clinical profile in North India: similarities and differences with other geographical regions of India. Indian J Cancer 2013;50:291.
  114. Singh N, Aggarwal AN, Gupta D, Behera D, Jindal SK. Unchanging clinico-epidemiological profile of lung cancer in north India over three decades. Cancer Epidemiol 2010;34:101.4.
  115. Jindal SK, Malik SK, Dhand R, Gujral JS, Malik AK, Datta BN. Bronchogenic carcinoma in Northern India. Thorax 1982;37:343.7.
  116. Singh N, Aggarwal AN, Gupta D, Behera D, Jindal SK. Quantified smoking status and non-small cell lung cancer stage at presentation: analysis of a North Indian cohort and a systematic review of literature. J Thorac Dis 2012;4:474.84.
  117. Singh N, Aggarwal AN, Gupta D, Behera D. Prevalence of low body mass index among newly diagnosed lung cancer patients in North India and its association with smoking status. Thoracic Cancer 2011;2:27.31.
  118. Jindal SK, Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D, et al. Tobacco smoking in India: prevalence, quit-rates and respiratory morbidity. Indian J Chest Dis Allied Sci 2006;48:37.42.
  119. Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, et al. ICMR-NCDIR-NCRP Investigator Group. Cancer statistics, 2020: report from National Cancer Registry programme, India. J Glob Oncol 2020;6:1063.75. doi: 10.1200/GO.20.00122. PMID: 32673076; PMCID: PMC7392737.
  120. Sarkar S, Datta D, Debbarma S, Majumdar G, Mandal SS. Patterns of cancer incidence and mortality in North- Eastern India: the first report from the population based cancer registry of tripura. Asian Pac J Cancer Prev 2020;21:2493.9.
  121. Smith RD, Mallath MK. History of the growing burden of cancer in India: from antiquity to the 21st Century. J Glob Oncol 2019;5:1.15.
  122. Gharpure PV. The incidence of primary carcinoma in India as inferred from post-mortem records of fifty years from 1877 to 1926. Indian Med Gaz 1927;62:315.7.
  123. Gharpure PV. Pathological evidence bearing on the incidence of diseases in Bombay. Indian Med Gaz 1928;63:253.9.
  124. Gharpure PV. Incidence of primary carcinoma of the liver and other organs as inferred from autopsy work, 1926 to
  125. Indian Med Gaz 1948;83:5.6.
  126. Mitra S, Dasgupta A. An estimate of the prevalence of cancer in India. Bull World Hlth Organ 1960;22:485.2.
  127. Vincent RG, Pickren JW, Lane WW, Bross I, Takita H, Houten L, et al. The changing histopathology of lung cancer: a review of 1682 cases. Cancer 1977;39:1647.55.
  128. Lu T, Yang X, Huang Y, Zhao M, Li M, Ma K, et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manage Res 2019;11:943.53.
  129. Loeb LA, Emster VL, Warner KE, Abbotts J, Laszlo J. Smoking and lung cancer: an overview. Cancer Res 1984;44:5940–58.
  130. Cornfield J, Haenszel W, Hammond EC, Lilienfeld AM, Shimkin MB, Wynder EL. Smoking and lung cancer: recent evidence and a discussion of some questions. J Natnl Canst 1959;22:173–203.
  131. Keeffe LM, Taylor G, Huxley RR, Mitchell P, Woodward M, Peters SAE. Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis. BMJ Open 2018;8:e021611. doi: 10.1136/bmjopen-2018-021611.
  132. Bade BC, Cruz CSD. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med 2020;41:1–24.
  133. Notani P, Sanghavi LD. A retrospective study of lung cancer in Bombay. Br J Cancer 1974;29:477–82.
  134. Jussawala DJ, Jain DK. Lung cancer in greater Bombay correlation with religion and smoking habits. Br J Cancer 1979;40:437–48.
  135. Pakhale SS, Jayant K, Bhide SV. Methods of reduction of harmful constituents in bidi smoke. Indian J Chest Dis Allied Sci 1985;27:148–52.
  136. Prasad R, Ahuja RC, Singhal S, Srivastava AN, James P, Kesarwani V, et al. A case-control study of bidi smoking and bronchogenic carcinoma. Ann Thorac Med 2010;5:238–41.
  137. Gupta D, Boffetta P, Gaborieau V, Jindal SK. Risk factors of lung cancer in Chandigarh, India. Indian J Med Res 2001;113:142–50.
  138. Gajalakshmi V, Hung RJ, Mathew A, Varghese C, Brennan PK. Tobacco smoking and chewing, alcohol drinking and lung cancer risk among men in southern India. Int J Cancer 2003;107:441–7.
  139. Notani PN, Rao DN, Sirsat MV, Sanghvi LD. A study of lung cancer in relation to bidi smoking in different religious communities in Bombay. Indian J Cancer 1977;14:115–21.
  140. Jayalekshmy PA, Akiba S, Madhavan MK, Gangadharan P, Rajan P, Nair RK, et al. Bidi smoking and lung cancer incidence among males in Karunagappally cohort in Kerala, India. Int J Cancer 2008;123:1390–7.
  141. Koul PA, Hajni MR, Sheikh MA, Khan UH, Shah A, Khan Y, et al. Hookah smoking and lung cancer in the Kashmir valley of the Indian subcontinent. Asian Pac J Cancer Prev 2011;12:519–24.
  142. Zhong L, Goldberg MS, Parent ME, Hanley JA. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer 2000;27:3–18.
  143. Sun S, Schiller J, Gazda, A. Lung cancer in never smokers: a different disease. Nat Rev Cancer 2007;7:778–90.
  144. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007;25: 561–70.
  145. Couraud S, Zalcman G, Milleron B, Morin F, Souquet P. Lung cancer in never smokers: a review Eur J Cancer 2012;48:1299–11.
  146. Rapiti E, Jindal SK, Gupta D, Boffetta P. Passive smoking and lung cancer in Chandigarh, India. Lung Cancer 1999;23:183–9.
  147. Behera D, Balamugesh T. Indoor air pollution as a risk factor for lung cancer in women. J Assoc Physicians India 2005;53:190–2.
  148. Torres-Duque C, Maldonado D, Pérez-Padilla R, Ezzati M, Viegi G, on behalf of the Forum of International Respiratory Societies (FIRS) Task Force on Health Effects of Biomass. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc 2008;5:577–90.
  149. Kurmi OP, Lam KBH, Ayres JG. Indoor air pollution and the lung in low- and medium-income countries. Eur Respir J 2012;40:239–54.
  150. World Health Organization. Household air pollution and health. Available from URL: https://www.who.int/news-room/fact-sheets/detail/household-air-pollution-and-health. Accessed on May 6, 2021.
  151. Kumar R. Air pollution and respiratory health. J Adv Pediatr Child Health 2020;3:032–7.
  152. Wong IC, Ng YK, Lui VW. Cancers of the lung, head and neck on the rise: perspectives on the genotoxicity of air pollution. Chinese J Cancer 2014;33:476–80.
  153. Turner MC, Andersen ZJ, Baccarelli A, Diver WR, Gapstur SM, Pope A, et al. Outdoor air pollution and cancer: an overview of the current evidence and public health recommendations. CA Cancer J Clin 2020;70:460–79.
  154. Christiani DC. Occupational exposures and lung cancer. Am J Respir Crit Care Med 2020;202:317–9.
  155. Hagedoorn P, Vandenheede H, Willaert D, Vanthomme K, Gadeyne S. Regional inequalities in lung cancer mortality in Belgium at the beginning of the 21st Century: the contribution of individual and area-level socioeconomic status and industrial exposure. PLoS One 2016;11:e0147099.
  156. Barrera-Rodriguez R, Morales-Fuentes J. Lung cancer in women. Lung Cancer (Auckland) 2012;3:79–89. doi:10.2147/LCTT.S37319.
  157. Domagala-Kulawik J, Trojnar A. Lung cancer in women in 21th century. J Thorac Dis 2020;12:4398–4410.
  158. Trojnar A, Domagała-Kulawik J. Lung cancer in women: is gynecological and obstetrical history important? Oncol Clin Pract 2021;17: DOI: 10.5603/OCP.2021.2021.0004.
  159. Slebos RJ, Rodenhuis S. The molecular genetics of human lung cancer. Eur Respir J 1989;2:461–9.
  160. Rom WN, Hay JG, Lee TC, y Jiang Y, Tchou-Wong K. Molecular and genetic aspects of lung cancer. Am J Respir Crit Care Med 2000;161:1355–67.
  161. Wang J, Liu Q, Yuan S, Xie W, Liu Y, Xiang Y, et al. Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies. Sci Rep 2017;7:8371. https://doi.org/10.1038/s41598-017-07737-0.
  162. Mir S, Radhika S, Wali A, Majumdar S, Joshi K, Behera D. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL and Bax in locally advanced squamous cell carcinoma of the lung. Lung Cancer 2004;45:181–8.
  163. Wali A, Srinivasan R, Shabnam MS, Majumdar S, Joshi K, Behera D. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation. Mol Cancer Res 2006;4:93–99.
  164. Malhotra P, Behera D, Srinivasan R, Majumdar S, Wali A, Mir S, et al. Detection of microsatellite alterations in bronchial washings in squamous cell lung cancer: the first study from India. Japanese J Clin Oncol 2004;34:439–44.
  165. Mehta S, Chhetra R, Srinivasan R, Sharma SC, Behera D, Ghosh S. Detection of disease specific sialoglycoconjugate specific antibodies in bronchoalveolar lavage fluid of nonsmall cell lung cancer patients. Glycocon J 2010;27:491–500.
  166. Singh N, Mootha VK, Madan K, Aggarwal AN, Behera D. Tumor cavitation among lung cancer patients receiving first-line chemotherapy at a tertiary care centre in India: association with histology and overall survival. Med Oncol 2013;30:602. doi: 10.1007/s12032-013-0602-z.
  167. Behera D. FHIT gene expression in lung cancer celllines and evaluation of its effects with chemotherapeutic agents on apoptosis. J Thorac Oncol 2007;2(Suppl. 4):S482.
  168. Pasrija T, Srinivasan R, Behera D, Majumdar S. Telomerase activity in sputum and telomerase and its components in biopsies of advanced lung cancer. Eur J Cancer 2007;43:1476–82.
  169. Mehta S, Chhetra R, Srinivasan R, Sharma SC, Behera D, Ghosh S. Potential importance of Maackia amurensis agglutinin in non-small cell lung cancer. Biol Chem 2013;394:889–900.
  170. Kamath A, Joseph AM, Gupta K, Behera D, Jaiswal A, Dewan R, et al. Proteomic analysis of HEK293 cells expressing non small cell lung carcinoma associated epidermal growth factor receptor variants reveals induction of heat shock response. Exp Hematol Oncol 2015;4:16.
  171. Sodhi KK, Bahl C, Singh N, Behera D, Sharma S. Functional genetic variants in pre-miR-146a and 196a2 genes are associated with risk of lung cancer in North Indians. Future Oncol 2015;11:2159–73.
  172. Singh N, Bansal R, Behera D, Gupta A. Intravitreal bevacizumab for choroidal metastases: the key to efficacy is simultaneous administration of systemic therapy. Eye 2015;29:1629.
  173. Mehta S, Chhetra R, Srinivasan R, Sharma SC, Behera D, Ghosh S. Corrigendum to: Potential importance of Maackia amurensis agglutinin in non-small cell lung cancer. Biol chem 2015;396:1377–8.
  174. Sharma N, Singh A, Singh N, Behera D, Sharma S. Genetic polymorphisms in GSTM1, GSTT1 and GSTP1 genes and risk of lung cancer in a North Indian population. Cancer Epidemiol 2015;39:947–55.
  175. Girdhar Y, Singh N, Behera D, Sharma S. Combinations of the variant genotypes of CYP1A1, GSTM1 and GSTT1 are associated with an increased lung cancer risk in north indian population: a case-control study. Pathol Oncol Res 2016;22:647–52.
  176. Singh A, Singh N, Behera D, Sharma S. Association and multiple interaction analysis among five XRCC1 polymorphic variants in modulating lung cancer risk in North Indian population. DNA Repair 2016;47:30–41.
  177. Kumari A, Bahl C, Singh N, Behera D, Sharma S. Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinumbased chemotherapy. Mol Biol Rep 2016;43:1383–94.
  178. Girdhar Y, Singh N, Behera D, Sharma S. Synergistic association of CYP1A1 polymorphisms with increased susceptibility to squamous cell lung cancer in north Indian smokers. Int J Biol Markers 2016;31:e402–e412.
  179. Watts A, Singh B, Basher R, Singh H, Bal A, Kapoor R, et al. 68Ga-Pentixafor PET/CT demonstrating higher CXCR4 density in small cell lung carcinoma than in nonsmall cell variant. Eur J Nucl Med Mol Imag 2017;44:909–10.
  180. Bahl C, Singh N, Behera D, Sharma S. Association of polymorphisms in Dickopff (DKK) gene towards modulating risk for lung cancer in north Indians. Future Oncol 2017;13:213–32.
  181. Lawania S, Singh N, Behera D, Sharma S. XPC polymorphism and risk for lung cancer in north indian patients treated with platinum based chemotherapy and its association with clinical outcomes. Pathol Oncol Res 2018;24:353–66.
  182. Bahl C, Sharma S, Singh N, Behera D. Association study between genetic variations in Axin2 gene and lung cancer risk in North Indian population: a multiple interaction analysis. Tumour Biol 2017;39:1010428317695533. doi: 10.1177/1010428317695533.
  183. Singh A, Singh N, Behera D, Sharma S. Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapy. Med Oncol 2017;34:64. DOI: 10.1007/s12032-017-0923–4.
  184. Lawania S, Singh N, Behera D, Sharma S. Association of XPA polymorphisms towards lung cancer susceptibility and its predictive role in overall survival of North Indians. Biochem Genet 2018;56:375–96.
  185. Bhardwaj A, Bahl C, Sharma S, Singh N, Behera D. Interactive potential of genetic polymorphism in xenobiotic metabolising and DNA repair genes for predicting lung cancer predisposition and overall survival in North Indians. Mutat Res 2018;826:15–24.
  186. Singh A, Singh N, Behera D, Sharma S. Role of polymorphic XRCC6 (Ku70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapy. Mol Biol Rep 2018;45:253–61.
  187. Singh A, Singh N, Behera D, Sharma S. Genetic investigation of polymorphic OGG1 and MUTYH genes towards increased susceptibility in lung adenocarcinoma and its impact on overall survival of lung cancer patients treated with platinum b
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.